Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
about
Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection MethodsReviving old antibioticsCarbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.Differences in Inflammatory Response Induced by Two Representatives of Clades of the Pandemic ST258 Klebsiella pneumoniae Clonal Lineage Producing KPC-Type Carbapenemases.φBO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic Clonal Group 258 clade II lineageDifferential Th17 response induced by the two clades of the pandemic ST258 Klebsiella pneumoniae clonal lineages producing KPC-type carbapenemase.Recurrent detection of VIM-1-producing Escherichia coli clone in German pig productionCharacterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries.Large Nosocomial Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Traced to Clonal Expansion of an mgrB Deletion Mutant.Assessment of free fatty acids and cholesteryl esters delivered in liposomes as novel class of antibiotic.Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial DominanceMolecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem.Differential Regulation of the Surface-Exposed and Secreted SslE Lipoprotein in Extraintestinal Pathogenic Escherichia coli.A Rapid Spin Column-Based Method to Enrich Pathogen Transcripts from Eukaryotic Host Cells Prior to Sequencing.A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.Colonization resistance: The deconvolution of a complex trait.Further Spread of bla NDM-5 in Enterobacteriaceae via IncX3 Plasmids in Shanghai, ChinaSerotype epidemiology and multidrug resistance patterns of Salmonella enterica infecting humans in ItalyStability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases.Host-mediated sugar oxidation promotes post-antibiotic pathogen expansionAntibiotic Resistance of Bacteria Involved in Urinary Infections in Brazil: A Cross-Sectional and Retrospective Study.Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients.Altered Outer Membrane Transcriptome Balance with AmpC Overexpression in Carbapenem-Resistant Enterobacter cloacaeSensitivity to Antimicrobial Drugs of Pseudomonas Aeruginosa Extreme-Resistant Strains Isolated in the Major Hospitals of Central Kazakhstan.Combination therapy for carbapenem-resistant Enterobacteriaceae: increasing evidence, unanswered questions, potential solutions.Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model.Therapeutic options for carbapenem-resistant Enterobacteriaceae infections.The rapid spread of carbapenem-resistant Enterobacteriaceae.Carbapenem-resistant Enterobacteriaceae in the community: a scoping review.Empirical monotherapy with meropenem or combination therapy: the microbiological point of view.Infections due to Carbapenem Resistant Enterobacteriaceae among Saudi Arabian Hospitalized Patients: A Matched Case-Control Study.Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013-2014.Co-production of NDM-1 and OXA-232 by ST16 Klebsiella pneumoniae, Italy, 2016.Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.Risk factors and mortality in the Carbapenem-resistant Klebsiella pneumoniae infection: case control study.A randomized clinical trial on the effectiveness of a symbiotic product to decolonize patients harboring multidrug-resistant Gram-negative bacilli.Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: increasing diversity with predominance of the ST512 clade II sublineage.Uropathogen distribution and antimicrobial susceptibility in uncomplicated cystitis in Belgium, a high antibiotics prescribing country: 20-year surveillance.A combined disc method with resazurin agar plate assay for early phenotypic screening of KPC, MBL and OXA-48 carbapenemases among Enterobacteriaceae.Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study.
P2860
Q26744583-61390476-C09A-4258-A59D-521B38BF21CCQ26853271-858DDECC-3765-4B3A-8B89-32E172320944Q30148824-9E88EF98-A436-4205-8354-91236B309052Q30397403-706B268B-0EA5-4D1F-BE64-D1E32828BDD5Q30402653-75B930F9-76B3-45C5-B937-59B5E5D1A6DAQ30402773-CB9EFF13-DEDB-477D-9190-BC7E9A40E207Q33589795-318F538C-9524-461B-97C7-2949C65C9107Q35996924-03DF2856-19CB-4D01-BB96-91FE45B3DE8BQ36066797-4D87BBCC-52BA-4BFF-BD18-324128AAA272Q36071267-4141E843-D3D4-4750-8FE4-D1AC90FAC6C7Q36076066-3D3E7E5A-BD49-4499-ACDE-559C800A331DQ36120398-E3179214-F9EA-4AEB-BEAD-87EEDB0A72D9Q36124083-220E3CEA-75B6-46B7-A3F6-FE38446E5EC3Q36230535-8DC1F2F9-7F53-4A89-BA19-5D760B354AB5Q36260443-219E1168-8156-4B08-8DD7-24DA46420AB4Q36340549-F063B471-2D8F-420A-A1C9-A2E8BA33AEF3Q36740310-0560CA0C-8F22-43D0-94E0-42F0461C0438Q36955451-56CB885C-FBE9-49B3-8B27-B01D46AA39CBQ37023305-CDB3E552-8538-4E64-A34A-C50B5D0224E8Q37080879-AE2F6477-CAF5-489B-A15D-C975A5F675CFQ37283896-43F375B6-F135-4FDC-B5C2-52511BC6CC5FQ37287753-8598C925-926C-4D23-B100-54DCE9BBACCEQ37528489-E2FB966E-AEC8-4714-B7D5-00C1C0492CE5Q37658746-E9450C8C-DFF6-41C4-9518-0A40E0A48556Q38585583-677AE14E-07A9-4AC1-B030-09EDBDA439BDQ38891891-0A38CCAA-97FF-4A76-8A60-56242B8CFE2DQ38918458-B6095FC0-6FB1-4CDD-8BD8-B6DC87260E81Q39027434-5487076D-391B-4826-9C50-A6110EB25CD8Q39396465-240D0ED9-1B57-4266-8016-1AA769908493Q39510473-1E751D6A-98A8-4180-B87D-0C97AE0D81A6Q39796166-107CF2B5-A66C-4E09-BD67-88E857110B4DQ39812263-E4EE82B9-F871-4F61-8C71-F54CA996B9F7Q40056360-1A197A3A-E879-4128-95E4-0B5A1855C841Q40358195-7AC5C7D7-BC42-4A3A-A14D-57AC2CEC2B37Q40429262-1BC98577-19BA-4ED1-8E93-FB1A9CFD090CQ40464218-80F20054-EA2D-4A00-A1B8-10DB59382877Q40554648-1AF9CA13-3F3C-442A-A8CF-E98FEB65C230Q40576999-BF44DA8D-5B95-45A9-81D5-FF65DA38E7D3Q40648628-DC233893-7FC1-462A-9E9C-E4E6FFDBC667Q40734670-E2E107F4-668F-473A-84CA-282E41552EDF
P2860
Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Global dissemination of extens ...... eatment and infection control.
@en
type
label
Global dissemination of extens ...... eatment and infection control.
@en
prefLabel
Global dissemination of extens ...... eatment and infection control.
@en
P2860
P356
P1476
Global dissemination of extens ...... eatment and infection control.
@en
P2093
P2860
P304
P356
10.1111/JOIM.12342
P407
P577
2015-01-27T00:00:00Z